NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors
NeOnc Technologies Holdings (future NASDAQ: NTHI) has appointed former Beverly Hills Mayor Jimmy Delshad to its Board of Directors. Delshad, currently serving as global ambassador for Cedars Sinai International, brings extensive experience in management, technology, and community engagement.
As the first Iranian American mayor of Beverly Hills, Delshad is known for implementing 'Smart City' initiatives and has over 20 years of consulting experience across multiple sectors. He holds a computer science degree from UC (CSUN) and serves as Chairman of American International Business, Inc.
The appointment aims to leverage Delshad's expertise in strategic growth, fundraising, and community relations to support NeOnc's mission of developing treatments for brain and Central Nervous System diseases.
NeOnc Technologies Holdings (futuro NASDAQ: NTHI) ha nominato l'ex sindaco di Beverly Hills Jimmy Delshad nel suo Consiglio di Amministrazione. Delshad, attualmente ambasciatore globale per Cedars Sinai International, porta con sé una vasta esperienza nella gestione, nella tecnologia e nel coinvolgimento della comunità.
Come primo sindaco iraniano-americano di Beverly Hills, Delshad è noto per aver implementato iniziative di 'Smart City' e ha oltre 20 anni di esperienza nella consulenza in diversi settori. Ha conseguito una laurea in informatica presso l'UC (CSUN) e ricopre il ruolo di Presidente di American International Business, Inc.
La nomina mira a sfruttare l'expertise di Delshad nella crescita strategica, nel fundraising e nelle relazioni con la comunità per supportare la missione di NeOnc di sviluppare trattamenti per le malattie del cervello e del sistema nervoso centrale.
NeOnc Technologies Holdings (futuro NASDAQ: NTHI) ha nombrado al ex alcalde de Beverly Hills Jimmy Delshad en su Junta Directiva. Delshad, que actualmente se desempeña como embajador global de Cedars Sinai International, aporta una amplia experiencia en gestión, tecnología y participación comunitaria.
Como el primer alcalde iraní-estadounidense de Beverly Hills, Delshad es conocido por implementar iniciativas de 'Ciudad Inteligente' y tiene más de 20 años de experiencia en consultoría en múltiples sectores. Tiene un título en ciencias de la computación de la UC (CSUN) y es presidente de American International Business, Inc.
La designación tiene como objetivo aprovechar la experiencia de Delshad en crecimiento estratégico, recaudación de fondos y relaciones comunitarias para apoyar la misión de NeOnc de desarrollar tratamientos para enfermedades del cerebro y del sistema nervioso central.
NeOnc Technologies Holdings (미래 NASDAQ: NTHI)는 전 베벌리 힐스 시장 Jimmy Delshad를 이사회에 임명했습니다. 현재 Cedars Sinai International의 글로벌 대사로 활동 중인 Delshad는 관리, 기술 및 지역 사회 참여에 대한 폭넓은 경험을 가지고 있습니다.
베벌리 힐스의 첫 이란계 미국인 시장으로서 Delshad는 '스마트 시티' 이니셔티브를 실행한 것으로 알려져 있으며, 여러 분야에서 20년 이상의 컨설팅 경험을 보유하고 있습니다. 그는 UC (CSUN)에서 컴퓨터 과학 학위를 취득했으며, American International Business, Inc.의 회장을 맡고 있습니다.
이번 임명은 Delshad의 전략적 성장, 자금 조달 및 지역 사회 관계에 대한 전문성을 활용하여 NeOnc의 뇌 및 중추 신경계 질환 치료 개발 미션을 지원하는 것을 목표로 하고 있습니다.
NeOnc Technologies Holdings (futur NASDAQ: NTHI) a nommé l'ancien maire de Beverly Hills Jimmy Delshad au sein de son Conseil d'Administration. Delshad, qui est actuellement ambassadeur mondial pour Cedars Sinai International, apporte une vaste expérience en gestion, technologie et engagement communautaire.
En tant que premier maire iranien-américain de Beverly Hills, Delshad est connu pour avoir mis en œuvre des initiatives de 'Ville Intelligente' et possède plus de 20 ans d'expérience en conseil dans divers secteurs. Il détient un diplôme en informatique de l'UC (CSUN) et est président d'American International Business, Inc.
Cette nomination vise à tirer parti de l'expertise de Delshad en matière de croissance stratégique, de collecte de fonds et de relations communautaires pour soutenir la mission de NeOnc de développer des traitements pour les maladies du cerveau et du système nerveux central.
NeOnc Technologies Holdings (zukünftige NASDAQ: NTHI) hat den ehemaligen Bürgermeister von Beverly Hills Jimmy Delshad in seinen Vorstand berufen. Delshad, der derzeit als globaler Botschafter für Cedars Sinai International tätig ist, bringt umfassende Erfahrungen in den Bereichen Management, Technologie und Gemeinschaftsengagement mit.
Als erster iranisch-amerikanischer Bürgermeister von Beverly Hills ist Delshad bekannt für die Umsetzung von 'Smart City'-Initiativen und verfügt über mehr als 20 Jahre Beratungserfahrung in verschiedenen Sektoren. Er hat einen Abschluss in Informatik von der UC (CSUN) und ist Vorsitzender von American International Business, Inc.
Die Ernennung zielt darauf ab, Delshads Expertise in strategischem Wachstum, Fundraising und Gemeinschaftsbeziehungen zu nutzen, um die Mission von NeOnc zur Entwicklung von Behandlungen für Erkrankungen des Gehirns und des zentralen Nervensystems zu unterstützen.
- Addition of experienced board member with extensive management and consulting expertise
- Strengthened leadership in fundraising and donor relations
- Enhanced potential for community engagement and strategic growth
- None.
Delshad adds broad management and financial expertise to the NeOnc team
WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, today announced that it has appointed the Honorable Jimmy Delshad to its Board of Directors. Delshad is the former mayor of the city of Beverly Hills, and the current global ambassador for the Cedars Sinai International organization, a dedicated team that speaks multiple languages and focuses specifically on helping the hospital’s international patients.
“We are honored to welcome Jimmy to our Board of Directors, where his diverse expertise and talents should serve us well as we continue our innovative work to advance our mission of the treatment of brain and Central Nervous System diseases,” said Dr. Thomas Chen, Chief Executive Officer of NeOnc.
The Honorable Jimmy Delshad is a visionary leader and two-time mayor of Beverly Hills, renowned for his transformative "Smart City" initiatives, which elevated Beverly Hills to new standards of safety and technological advancement. As the first Iranian American to serve as mayor in the United States, Delshad pioneered the integration of technology within city management, establishing Beverly Hills as a model for modern municipal governance.
With more than 20 years of consulting experience across multiple sectors, Delshad has been instrumental in advising organizations on growth strategies, community engagement, and leadership development. His contributions include impactful roles as Global Ambassador for Cedars Sinai International, where he promotes the hospital’s healthcare expertise in international markets, and as Chairman of American International Business, Inc., where he has led consulting projects spanning smart city solutions, healthcare, and technology. Delshad’s distinguished record in fundraising and donor relations, coupled with his leadership in non-profit organizations such as the Aleph Institute and Magbit Educational Foundation, underscores his commitment to philanthropy and community empowerment. Delshad holds a degree in computer science from the University of California (CSUN).
“I am honored to join NeOnc Technologies’ Board of Directors to support their efforts in advancing cancer treatment,” said Delshad. “With my experience in strategic growth and community engagement, I look forward to contributing to NeOnc’s mission of delivering transformative therapies that offer new hope to patients and families worldwide.”
“It is a pleasure welcoming Jimmy to NeOnc’s board of directors, where his multifaceted guidance will be invaluable in our growing company,” said Amir Heshmatpour, Executive Chairman of NeOnc Technologies. “Jimmy’s dedication to community relations and public service extends beyond his tenure as mayor, continuing today through his work as a goodwill ambassador and political advisor. We look forward to working with him as we develop and bring innovative health solutions to the clinic.”
ABOUT NEONC TECHNOLOGIES HOLDINGS, INC.
NeOnc Technologies Holdings, Inc. is a privately held clinical-stage life sciences company focused on the development and commercialization of central nervous system therapeutics that are designed to address the persistent challenges in overcoming the blood-brain barrier. The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s NEO100™ and NEO212™ therapeutics are in Phase II human clinical trials and are advancing under FDA Fast-Track and Investigational New Drug (IND) status.
The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.
For more about NeOnc and its pioneering technology, visit neonctech.com.
Important Cautions Regarding Forward Looking Statements
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Generally, such forward-looking statements include statements regarding expectations, possible or assumed future actions, business strategies, events or results of operations, including statements regarding our expectations or predictions or future financial or business performance or conditions and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate," or similar expressions. The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions. Actual results could differ materially from current projections or implied results. The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management are under no obligation, and expressly disclaim any obligation, to update, alter or otherwise revise any forward-looking statements following the date of this news release, whether because of new information, future events or otherwise, except as required by law.
Company Contact:
Patrick Walters
Chief Operations Officer
NeOnc Technologies Holdings, Inc.
info@neonc.com
Investor Relations:
Roger Pondel / Laurie Berman
PondelWilkinson Inc.
(310) 279-5980
rpondel@pondel.com
lberman@pondel.com
FAQ
What role will Jimmy Delshad play on NeOnc Technologies' (NTHI) Board of Directors?
What is Jimmy Delshad's background and experience bringing to NTHI?
When will NeOnc Technologies (NTHI) be listed on NASDAQ?
What is NeOnc Technologies' (NTHI) main business focus?
